ELI LILLY & Co — Director's Dealing 2026

Feb 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-01

Reporting Person: Ricks David A (Director, President, Chair, and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-01	Common Stock	M	31932	—	Acquired	547098.167	Direct
2026-02-01	Common Stock	F	14296.654	$1037.15	Disposed	532801.513	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-01	Restricted Stock Unit	$	M	31932	Disposed	2026-02-01	Common Stock (31932)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6685	Indirect
Common Stock	54117	Indirect
Common Stock	300	Indirect
Common Stock	68656	Indirect
Common Stock	7311.26	Indirect

Footnotes

F1: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.